Lindengrove Menomonee Falls: Antidepressant Monitoring Gap - WI
The resident, identified in inspection records as R36, began taking Sertraline HCl 100 mg daily on November 6, 2024. The facility's own medication administration record set a monitoring start date of November 4, two days earlier, with clear instructions: observe the resident each shift for side effects including sedation, drowsiness, blurred vision, urinary retention, elevated heart rate, muscle tremors, agitation, headache, skin rash, and excess weight gain, and document what was found.
Nobody did. Not once, across more than three months of daily doses.
The gap ran from November 4, 2024, through February 15, 2025, a stretch of roughly 103 days. Sertraline, commonly sold under the brand name Zoloft, carries a range of side effects that can be serious in elderly patients, including cardiac effects and significant sedation. The facility's own monitoring protocol existed precisely to catch those problems early. It produced no records at all.
Inspectors raised the issue on February 17, first approaching the Director of Nursing, identified in the report as DON-B, at 8:08 in the morning. The director said she didn't have the information but would look into it.
Six hours passed.
At 2:03 in the afternoon, the surveyor returned. DON-B confirmed what the morning conversation had already suggested: there was no side effect monitoring documentation for R36 from November 4 through February 15. None.
The surveyor came back again at 4:32 that afternoon, this time with the facility's Nursing Home Administrator, identified as NHA-A, also present. DON-B acknowledged the expectation had been clear. Staff should have completed the monitoring. The director confirmed the facility had no documentation to show they had. What the facility did have, DON-B told the surveyor, was a fresh start: monitoring had been initiated for R36 on February 15, the same day the gap apparently ended.
That date, February 15, is notable. It came before the inspection, which was completed March 3. The records don't explain what prompted the facility to begin monitoring on that specific date after more than three months of silence.
The inspection classified the violation as causing minimal harm or potential for actual harm, and noted that few residents were affected. The harm level designation reflects the regulatory framework inspectors use; it does not mean the lapse was inconsequential. A resident on a psychiatric medication for depression went through fall, into winter, without anyone recording whether the drug was working, whether it was causing problems, or whether anything about their condition had changed.
Depression itself carries serious risks in nursing home residents, including withdrawal, deterioration, and in severe cases, self-harm. Antidepressant monitoring requirements exist in part because the drugs used to treat it can introduce their own complications, ones that are manageable when caught early and harder to address when nobody has been watching.
The inspection report offers no information about whether R36 experienced any of the side effects the protocol was designed to detect. That's the problem. There's no way to know, because no one wrote anything down.
DON-B and NHA-A provided no additional information after the 4:32 meeting.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Lindengrove Menomonee Falls from 2025-03-03 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Corrections: We strive for accuracy in everything we publish. If you believe any fact in this article is incorrect, please contact us with details, and we will review and correct it promptly.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: November 21, 2026 · Our methodology
Lindengrove Menomonee Falls in MENOMONEE FALLS, WI was cited for violations during a health inspection on March 3, 2025.
The resident, identified in inspection records as R36, began taking Sertraline HCl 100 mg daily on November 6, 2024.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.
